Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | prochlorperazine | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | SGX-523 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.7 |
mRNA | VU0155056 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.018 | 0.7 |
mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.098 | 0.7 |
mRNA | JQ-1 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.7 |
mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | istradefylline | CTRPv2 | pan-cancer | AAC | 0.018 | 0.8 |